Identification of the metabolites of a new oxazolidinone MAO-A inhibitor in rat

By Naitoh T.   Kakiki M.   Kozaki T.   Mishima M.   Yuzuriha T.   Horie T.  

Xenobiotica, Vol. 27, Iss. 10, 1997-10 ,pp. : 1071-1089

Informa Healthcare

Access to resources Recommend Favorite

Absorption, distribution, metabolism and excretion of a new, 14C-labelled oxazolidinone MAO-A inhibitor in rat and dog

By Naitoh T.   Mishima M.   Kawaguchi S.   Matsui K.   Andoh T.   Kagei K.   Kakiki M.   Yuzuriha T.   Horie T.  

Xenobiotica, Vol. 27, Iss. 10, 1997-10 ,pp. : 1053-1070

Informa Healthcare

Access to resources Recommend Favorite

Stereospecific oxidation of the ( S )-enantiomer of RS-8359, a selective and reversible monoamine oxidase A (MAO-A) inhibitor, by aldehyde oxidase

By Itoh K.   Yamamura M.   Muramatsu S.   Hoshino K.   Masubuchi A.   Sasaki T.   Tanaka Y.  

Xenobiotica, Vol. 35, Iss. 6, 2005-06 ,pp. : 561-573

Informa Healthcare

Access to resources Recommend Favorite

New Carbohydrate-Derived S,S-Dioxothiochroman Derivatives and Their Unexpected Easy Epimerization at the Anomeric Position

By Kinfe Henok H.   Makolo Felix L.   Moshapo Paseka T.   Phasha Zanele H.  

Journal of Carbohydrate Chemistry, Vol. 32, Iss. 3, 2013-03 ,pp. : 193-204

Taylor & Francis Ltd

Access to resources Recommend Favorite

Species differences in the multiple-dose pharmacokinetics of the non-nucleoside reverse transcriptase inhibitor (NNRTI) UK-453,061 in animals and man: implications for safety considerations

By Walker D. K.   Davis J.   Houle C.   Gardner I. B.   Webster R.  

Xenobiotica, Vol. 39, Iss. 7, 2009-07 ,pp. : 534-543

Informa Healthcare

Access to resources Recommend Favorite